A medicine that may treat and prevent Covid-19 is now being tested in patients in multiple sites around the US, Regeneron Pharmaceuticals Inc. announced. If successful, Regeneron hopes it could be available by the fall.
It is the first trial of a Covid-19 antibody cocktail in the United States. If successful, Regeneron hopes it could be available by the fall. The clinical trial started Wednesday.
Antibodies are proteins the body naturally makes to protect the body from a threat like Covid-19. To make what's called monoclonal antibodies for an antibody cocktail, scientists comb through thousands of antibodies to figure out which ones fight the novel coronavirus most effectively.
Tarrytown, New York-based Regeneron has successfully created other US Food and Drug Administration-approved antibody therapies that fight eye problems, rheumatoid arthritis, cancer and cardiovascular disease. Regeneron's Ebola treatment worked so well, its clinical trial was stopped early in August 2019. Data showed it was better at saving lives than some of the other therapies being tested. The FDA accepted REGN-EB3 for priority review in April.
Regeneron scientists said they had spent years preparing for a pandemic like Covid-19."Most scientist have said for years there's potential for pandemics like this novel coronavirus to emerge," Regenron scientist Kristin Pascal previously told CNN."So we thought, let's be prepared."To get ready, Pascal and her team ran speed challenges to see exactly how fast they could create a treatment for an emerging threat.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
United Airlines Adds A Step To Check-In: Stating You Don't Have COVID-19 SymptomsTravelers must review the checklist when checking in online or at the airport and confirm — similar to how passengers must affirm they're not bringing explosives or banned materials on board.
続きを読む »
The United States has surpassed 2 million cases of Covid-19There are more than two million cases of coronavirus in America, according to a tally by Johns Hopkins University
続きを読む »
U.S. EPA orders Amazon, eBay to stop selling unsafe COVID-19 products -BloombergE-commerce companies Amazon Inc and eBay Inc have been instructed by the U.S. Environmental Protection Agency (EPA) to stop selling unproven or unsafe disinfectants, including products falsely marketed as killing COVID-19, on their platforms, Bloomberg reported https://bloom.bg/3fcuLg5 on Thursday.
続きを読む »
AstraZeneca wins fresh U.S. backing in race for COVID-19 treatmentAstraZeneca has secured support from the U.S. government to advance the development of antibody-based COVID-19 treatments as the British drugmaker ramps up efforts beyond its potential vaccine to combat the global health crisis.
続きを読む »
How Refugee Doctors Are Helping the U.S. Fight COVID-19 Even Without a Medical License‘I Have the Skills, I Have the Training.’ How Refugee Doctors Are Helping the U.S. Fight COVID-19 Even Without a Medical License
続きを読む »
Exclusive: Nearly 600 — And Counting — U.S. Health Workers Have Died of COVID-19 | HealthyWomenChristina Jewett and Melissa Bailey, Kaiser Health News and Danielle Renwick, The GuardianNearly 600 front-line health care workers appear to have died of COVID-19, according to Lost on the Frontline, a project launched by The Guardian and KHN that
続きを読む »